These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36015235)
1. Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides. Bajraktari-Sylejmani G; von Linde T; Burhenne J; Haefeli WE; Sauter M; Weiss J Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015235 [TBL] [Abstract][Full Text] [Related]
2. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs. Han HK; Rhie JK; Oh DM; Saito G; Hsu CP; Stewart BH; Amidon GL J Pharm Sci; 1999 Mar; 88(3):347-50. PubMed ID: 10052994 [TBL] [Abstract][Full Text] [Related]
3. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1. Peterson LW; Sala-Rabanal M; Krylov IS; Serpi M; Kashemirov BA; McKenna CE Mol Pharm; 2010 Dec; 7(6):2349-61. PubMed ID: 20929265 [TBL] [Abstract][Full Text] [Related]
4. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2. Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721 [TBL] [Abstract][Full Text] [Related]
5. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1). Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699 [TBL] [Abstract][Full Text] [Related]
6. Rapid and Sensitive Quantification of Intracellular Glycyl-Sarcosine for Semi-High-Throughput Screening for Inhibitors of PEPT-1. von Linde T; Bajraktari-Sylejmani G; Haefeli WE; Burhenne J; Weiss J; Sauter M Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371711 [TBL] [Abstract][Full Text] [Related]
7. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen. Omkvist DH; Brodin B; Nielsen CU Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987 [TBL] [Abstract][Full Text] [Related]
8. Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist. Surendran N; Covitz KM; Han H; Sadee W; Oh DM; Amidon GL; Williamson RM; Bigge CF; Stewart BH Pharm Res; 1999 Mar; 16(3):391-5. PubMed ID: 10213369 [TBL] [Abstract][Full Text] [Related]
9. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells. Covitz KM; Amidon GL; Sadée W Pharm Res; 1996 Nov; 13(11):1631-4. PubMed ID: 8956326 [TBL] [Abstract][Full Text] [Related]
10. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037 [TBL] [Abstract][Full Text] [Related]
11. Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1. Colas C; Masuda M; Sugio K; Miyauchi S; Hu Y; Smith DE; Schlessinger A Mol Pharm; 2017 Dec; 14(12):4685-4693. PubMed ID: 29111754 [TBL] [Abstract][Full Text] [Related]